Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis

Inclusion Criteria: * Male or female study participants, aged between 16 and 60 years-old. Patients aged between 16 and 18 years-old will provide additional Assent Form before enrollment in the trial; * Presence of a skin lesion characteristic of Tinea pedis, with diagnosis confirmed by direct mycological exam; * Absence of previous antifungic treatment for the lesion under study; * Absence of other significant diseases which, at the physician's discretion, could have an impact on subject's participation in the trial, according to protocol requirements, and study evaluations: medical history, blood pressure and heart rate measurements, physical examination and screening laboratory tests; * Ability to understand the nature and objectives of the trial, including risks and adverse events; willingness to cooperate with the researcher and proceed according to all study requirements, which shall be confirmed by Informed Consent Form signature. Exclusion Criteria: * Known hypersensitivity to ketoconazole or chemically related compounds; history of serious adverse reactions; * Screening laboratory tests results showing clinically relevant deviations that, at the researcher discretion, prevent the subject to participate in the trial due to possible risks; * Drugs addiction, including alcohol; * Use of any previous treatment to the lesion under study that, according to principal investigator best judgement, might interfere in study objectives; * Treatment, within 3 months before the trial, with any drugs known to have a well-established toxic potential to major organs; * Participation in any other experimental research or administration of any experimental drug within 6 months before this trial; * Pregnancy, labor or miscarriage with 12 weeks before study treatment; * Any conditions, according to investigator's best judgement, that prevents the subject to participate in the trial.